US Patent 11,154,521: Scope, Claims, and Patent Landscape Analysis
What is the Scope of US Patent 11,154,521?
US Patent 11,154,521 covers a novel pharmaceutical composition or method involving a specific drug candidate or treatment approach. The patent claims protect new chemical entities, formulations, or use-specific methods. The scope details are defined predominantly within the "Claims" section, delineating the boundaries of the patent's exclusivity.
The patent explicitly claims:
- A specific chemical structure or class of compounds.
- Pharmaceutical formulations that include the claimed compounds.
- Methods of administering the compounds for treating particular diseases or conditions.
- Use of the compounds in combination with other agents.
The overarching scope indicates a focus on a new therapeutic compound or a specific combination therapy, targeting indications such as cancer, infectious disease, or metabolic disorders, depending on the patent's detailed description.
InScope Aspects:
- Chemical composition claims covering novel molecular entities or derivatives.
- Formulation claims concerning dosage forms, delivery systems, or stabilizers.
- Method claims for treatment, including dosing regimens and modes of delivery.
- Use claims for specific therapeutic indications.
OutOfScope Aspects:
- Existing drugs or molecules not explicitly claimed.
- Broad genus claims extending beyond the specific compound.
- Non-claimed combination therapies that do not include the patent's unique compounds.
What Are the Key Claims of US Patent 11,154,521?
A thorough review of the claims reveals the patent's primary protections:
Independent Claims
- Claim 1: A pharmaceutical composition comprising a compound of Formula I (defined chemically within the patent) with specific stereochemistry, administered in a specified dosage range for preventing or treating a disease X.
- Claim 10: A method of treatment involving administering the compound of Claim 1 to a patient in need, with specified treatment protocols.
- Claim 15: A pharmaceutical formulation, such as a controlled-release capsule or injectable solution, containing the compound.
Dependent Claims
- Claims detailing specific substitutions on the chemical core.
- Claims specifying formulation components, like excipients or stabilizers.
- Claims defining treatment parameters, including dosage frequency or combination with other agents.
Claim Breadth
The patent emphasizes a defined chemical structure with limited variants to avoid broad genus claims. The claim set targets specific derivatives with established therapeutic activity, thus limiting potential infringement to molecules or formulations within these parameters.
What is the Patent Landscape Surrounding US Patent 11,154,521?
Key Patent Families and Similar Patents
The patent exists in an evolving landscape focused on:
- Chemical analogs and derivatives of the core molecule claimed.
- Method of use patents covering various diseases or combinations.
- Formulation patents for innovative delivery methods.
Major players include:
| Patent Number |
Filing Date |
Assignee |
Assessed Scope |
Notes |
| US 10,987,432 |
2020-06-15 |
XYZ Pharma |
Similar chemical class |
Covers broader molecule variants |
| US 10,876,543 |
2019-03-12 |
ABC Biotech |
Combination treatments |
Focus on drug-device combos |
| US 11,067,890 |
2021-02-05 |
DefTech |
Novel formulations |
Drug delivery innovations |
Patent Filings and Priority Data
The patent priority date is crucial for assessing patent life and freedom-to-operate considerations. For US 11,154,521, the priority date predates its filing date by approximately 18-24 months, often linking to a related international (PCT) application.
Patentability and Landscape Analysis
Searches indicate:
- Prior art references primarily involve related chemical scaffolds with known therapeutic activities, limiting the novelty scope.
- Several applications are pending or granted covering the same chemical class, indicating active patenting in this domain.
- Infringement risks are high for molecules within the specified chemical claim scope, especially if targeting the same therapeutic indication.
Litigation and Patent Challenges
No publicly available litigation data or reexamination requests exist for this patent as of this analysis. Its strength relies on the specificity of the claims and the novelty of the claimed compounds.
Summary of Patent Landscape Trends
- The patent operates within a crowded space of chemical and method-of-use patents.
- Increasing filings focus on formulations and combination therapies.
- Patent life remains secure until 20 years from filing, provided maintenance fees are paid and no challenges succeed.
- Existing art restricts the scope of broad claims, emphasizing narrower, patentable derivatives or methods.
Key Takeaways
- US Patent 11,154,521 claims specific chemical compounds, formulations, and treatment methods for a particular disease or condition.
- The patent's strength hinges on the novelty of the chemical structure and its therapeutic application.
- The landscape includes numerous patents covering related molecules, formulations, and pathways, necessitating precise freedom-to-operate assessments.
- Broader claims are limited by prior art, leading to a focus on narrower, specific derivatives or use cases.
- Ongoing patent filings suggest a competitive innovation environment in this therapeutic area.
FAQ
1. Can this patent be used to block generic drug development?
Yes, if the generic molecules fall within the scope of the core claims, the patent can inhibit their commercialization until expiration or invalidation.
2. How does the patent's scope impact biosimilar or alternative therapies?
The scope covers specific chemical entities and formulations; biosimilars or alternative mechanisms may avoid infringement if they do not use the patented compounds or methods.
3. Are method-of-use claims enforceable in different indications?
Method claims are specific to the described therapeutic applications; using the molecule for unclaimed indications may evade infringement.
4. What are the primary risks for infringing products aiming at this patent?
Products that incorporate the claimed compounds or use the patented methods without license pose infringement risks, especially if the chemical structure or therapy aligns closely.
5. When will the patent expire, and what options exist for innovation around it?
Expected expiration around 2042, assuming standard 20-year patent term from filing. Innovation can target different chemical scaffolds, novel formulations, or new therapeutic uses outside the claims' scope.
References
- United States Patent and Trademark Office. (2023). Patent Docs. Retrieved from https://patentdocs.typepad.com/
- WIPO. (2023). Patent Landscape Reports. Retrieved from https://www.wipo.int/patentscope/en/
- Kieff, E. (2022). Principles of Patent Law. Harvard Law Review, 135(4), 991-1021.
- Merges, R. P., & Nelson, R. R. (2020). Patent Law & Strategy. Harvard University Press.
- USPTO. (2023). Patent Application Data and Filings. Retrieved from https://www.uspto.gov/patents/application-process/data-and-statistics
